.
S O U R C E : Longevity for all
May 15, 2020
On May 15, representatives of 15 research institutions from 13 countries established an International Multi-Center Collaboration on Antiaging and Disease Prevention by signing a memorandum of understanding (MoU).
The collaboration will include representatives from the Institute of Basic Medical Sciences Chinese Academy of Medical Sciences & School of Basic Medicine Peking Union Medical College, China (Dr. Robert Chunhua Zhao); International Society on Aging and Disease, USA (Dr. Kunlin Jin); University of Valencia, Spain (Dr. Antonio Cano); University of Nice, France (Dr. Eric Gilson); University of Palermo, Italy (Dr. Calogero Caruso); Maharishi Markandeshwar Deemed University, India (Dr. Sasanka Chakrabarti); King’s College London, UK (Dr. Georgina Ellison-Hughes); European Academy of Sciences, Arts and Humanities, France (Dr. Ante Glibota); University of Toronto, Canada (Dr. Armand Keating); University of Hong Kong, China (Dr. Lee Wei Lim); Syktyvkar State University, Russian Federation (Dr. Alexey Moskalev); Inha University, Republic of Korea (Dr. Kyung-Jin Min); University of Macau, China (Dr. Huanxing Su); Vetek (Seniority) – the Movement for Longevity and Quality of Life, Israel (Dr. Ilia Stambler); Karolinska Institutet, Stockholm, Sweden (Dr. Brun Ulfhake).
This collaboration followed the establishment of the Executive Committee on Anti-aging and Disease Prevention in the framework of Science and Technology, Pharmacology and Medicine.
Themes under an Interactive Atlas along the Silk Roads, UNESCO. The committee inauguration took place during the 2nd (Beijing) Annual International Biomedical Health Conference and the 1st Academician Forum of Transnational Biomedical Field, in Beijing, on December 16, 2019[1]. The committee members outlined collaboration opportunities among the institutions involved.
The resulting international collaboration will focus on Anti-aging and Prevention of both communicable and non-communicable diseases. This will advance an integrative and preventive approach to diseases as it considers aging processes as the major risk factors of both communicable and non-communicable diseases that need to be addressed by prevention and therapy.
The recent evidence of the strong risks of unfavorable outcomes among the elderly and frail COVID-19 patients further emphasizes the validity of this approach and the need for international cooperation in this area. [2]
The collaboration will advance international academic research, innovation and knowledge exchange in relation to:
- Data sharing for research and development around detection, treatment and prevention of degenerative aging and aging-related diseases, their prevalence, risk factors, evaluation criteria and effective counter-measures.
- Building working groups around strategic areas of antiaging and disease prevention to select diagnostics and interventions for further development.
- Implementing projects, publications and meetings around risk factor assessment, regulation/policy, education, diagnosis and interventions for antiaging and disease prevention.
- Creating academic and public awareness about the role of aging and its amelioration in both non-communicable and communicable diseases. Thus, beside the traditional emphasis on the relation of aging and non-communicable diseases such as heart disease, neurodegenerative diseases, diabetes mellitus, cancer, COPD, etc., this collaboration will also advance the understanding about the role of aging processes and their amelioration in communicable diseases, such as COVID-19. The latter goal will include exploring and advancing therapies that show promise to improve the underlying aging processes, such as the immune function of the elderly, e.g. utilizing mesenchymal stem cells.
.../...
.
Edited by Engadin, 15 May 2020 - 08:02 PM.
